Cancer Trials Ireland
- Country
- 🇮🇪Ireland
- Ownership
- Private
- Established
- 1996-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.cancertrials.ie
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5
- First Posted Date
- 2012-03-29
- Last Posted Date
- 2021-12-23
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 43
- Registration Number
- NCT01566747
- Locations
- 🇮🇪
Beaumont Hospital, Dublin, Leinster, Ireland
🇮🇪Mater Misericordiae University Hospital, Dublin, Leinster, Ireland
🇮🇪Mater Private Hospital, Dublin, Leinster, Ireland
A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2012-02-03
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 75
- Registration Number
- NCT01526369
- Locations
- 🇫🇮
Helsinki University Hopsital, Helsinki, Finland
🇪🇸Hospital Nuestra Senora de Sonsoles, Avila, Spain
🇪🇸Hospital Clinico Universitario 'Lozano Blesa', Zaragoza, Spain
The Myocet/Lapatinib Study. ICORG 10-03, V5
- Conditions
- Interventions
- First Posted Date
- 2011-12-20
- Last Posted Date
- 2015-10-26
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 11
- Registration Number
- NCT01495884
- Locations
- 🇮🇪
University Hospital Limerick, Limerick, Ireland
🇮🇪Bon Secours Hospital, Cork, Ireland
🇮🇪St. Vincent's University Hospital, Dublin, Ireland
A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab) and TCHL (Docetaxel, Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients.
- Conditions
- Interventions
- First Posted Date
- 2011-12-06
- Last Posted Date
- 2018-08-06
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 120
- Registration Number
- NCT01485926
- Locations
- 🇮🇪
Waterford Regional Hospital, Waterford, Ireland
🇮🇪St James's Hospital, Dublin, Leinster, Ireland
🇮🇪St Vincent's University Hospital, Dublin, Leinster, Ireland
Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34
- First Posted Date
- 2010-08-06
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 40
- Registration Number
- NCT01176487
- Locations
- 🇮🇪
St Luke's Radiation Oncology Network (SLRON), Dublin, Ireland
🇮🇪Galway University Hospital, Galway, Ireland
Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06
- Conditions
- Interventions
- First Posted Date
- 2010-07-16
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 92
- Registration Number
- NCT01164150
- Locations
- 🇮🇪
St Luke's Centre for Radiation Oncology at St Lukes Hospital, Dublin 6, Ireland
🇮🇪Mid-Western Radiation Oncology Centre, Limerick, Ireland
🇮🇪St Luke's Centre for Radiation Oncology at St James Hospital, Dublin 8, Ireland
Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2
- Conditions
- First Posted Date
- 2010-07-12
- Last Posted Date
- 2020-11-17
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 73
- Registration Number
- NCT01160705
- Locations
- 🇮🇪
Beaumont Hospital, Dublin, Ireland
🇮🇪Mater Private Hospital, Dublin, Ireland
🇮🇪Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital, Dublin, Ireland
Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2010-07-12
- Last Posted Date
- 2014-12-31
- Lead Sponsor
- Cancer Trials Ireland
- Registration Number
- NCT01160731
Sorafenib. ICORG 06-41, V4
- Conditions
- Interventions
- First Posted Date
- 2010-07-08
- Last Posted Date
- 2014-12-31
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 54
- Registration Number
- NCT01158287
- Locations
- 🇮🇪
Cork University Hospital, Cork, Ireland
🇮🇪Waterford Regional Hospital, Waterford, Ireland
🇮🇪Mater Misericordiae University Hospital, Dublin, Ireland
Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
- Conditions
- First Posted Date
- 2009-09-10
- Last Posted Date
- 2017-05-24
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 803
- Registration Number
- NCT00974610
- Locations
- 🇮🇪
Mater Private Hospital, Dublin, Ireland
🇮🇪Mid-Western Cancer Centre at Mid-Western Regional Hospital, Limerick, Ireland
🇮🇪Cork University Hospital, Cork, Ireland